5-fluoropyrimidine has been researched along with Adenocarcinoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, J; Jiang, ZQ; Katz, M; Kopetz, S; Lee, JE; Overman, MJ; Shroff, R; Varadhachary, G; Wang, H; Wang, X; Wolff, RA | 1 |
| Arrowsmith, ER; Bajetta, E; Del Prete, SA; Fuchs, CS; Hwang, J; Jin, J; Malek, K; Ng, K; Ryan, DP; Sedova, M; Sharma, S; Tabernero, J | 1 |
| Cao, Y; Gong, J; Li, J; Li, Y; Lu, M; Lu, Z; Shen, L; Wang, X; Wu, Y; Zhang, X; Zhou, J | 1 |
| Cho, HM; Chung, MJ; Jang, HS; Kim, HJ; Kim, SH; Kye, BH; Lee, JH; Lee, JW; Shim, BY | 1 |
| Araki, K; Dabanaka, K; Hanazaki, K; Hokimoto, N; Kobayashi, M; Maeda, H; Munekage, M; Namikawa, T; Okabayashi, T; Sugimoto, T | 1 |
| Ng, S; O'bichere, A; Platell, C; Tebbutt, N | 1 |
| Boku, N; Honma, Y; Kato, S; Kawai, H; Morita, S; Nishina, T; Suenaga, M; Taguri, M; Takahashi, H; Tamura, F; Tsushima, T; Ueda, S | 1 |
| El-Rayes, BF; Zafar, SF | 1 |
| Calin, GA; Dubois, RN; Ellis, LM; Eng, C; Gu, J; Hawk, ET; Hildebrandt, MA; Huang, M; Lin, J; Lin, M; Wang, D; Wu, X | 1 |
| Cao, S; Gibbs, JF; Rustum, YM; Slocum, HK | 1 |
| Heimburger, DK; Lawrence, TS; Shewach, DS | 1 |
| Holbrook, CT; Klann, RC; Nyce, J | 1 |
| Houghton, JA; Houghton, PJ | 1 |
| Lönn, S; Lönn, U | 1 |
| Christensson, PI; Erichsen, C; Jönsson, PE; Stenram, U | 1 |
2 review(s) available for 5-fluoropyrimidine and Adenocarcinoma
| Article | Year |
|---|---|
Chemotherapeutic strategies in advanced or metastatic pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Molecular Targeted Therapy; Pancreatic Neoplasms; Pyrimidines | 2014 |
Reduced folates and fluoropyrimidine antitumor efficacy.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Folic Acid; Humans; Pyrimidines; Tumor Cells, Cultured | 1989 |
1 trial(s) available for 5-fluoropyrimidine and Adenocarcinoma
| Article | Year |
|---|---|
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Class I Phosphatidylinositol 3-Kinases; Colorectal Neoplasms; Disease-Free Survival; DNA Mutational Analysis; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Phosphatidylinositol 3-Kinases; Prospective Studies; Proto-Oncogene Proteins B-raf; Pyrimidines; Sirolimus; Treatment Outcome | 2013 |
12 other study(ies) available for 5-fluoropyrimidine and Adenocarcinoma
| Article | Year |
|---|---|
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.
Topics: Adenocarcinoma; Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Deoxycytidine; Duodenal Neoplasms; Female; Gemcitabine; Humans; Male; Pancreatic Neoplasms; Pyrimidines; Retrospective Studies; Survival; Treatment Outcome | 2013 |
[Trastuzumab combined with chemotherapy in patients with HER2-positive chemo-refractory advanced gastric or gastro-esophageal junction adenocarcinoma].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Esophagogastric Junction; Fatigue; Female; Follow-Up Studies; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Pyrimidines; Receptor, ErbB-2; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Rate; Trastuzumab | 2014 |
KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery.
Topics: Adenocarcinoma; Aged; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrimidines; ras Proteins; Rectal Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.
Topics: Adenocarcinoma; Disease-Free Survival; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Pyrimidines; Stomach Neoplasms; Time Factors | 2009 |
Changing management and survival in patients with stage IV colorectal cancer.
Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Antineoplastic Agents; Australia; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Colostomy; Deoxycytidine; Female; Fluorouracil; Humans; Irinotecan; Male; Multivariate Analysis; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Proportional Hazards Models; Pyrimidines; Radiotherapy, Adjuvant; Survival Rate | 2011 |
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Female; Humans; Intestinal Neoplasms; Intestine, Small; Irinotecan; Japan; Male; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Oxaliplatin; Pyrimidines; Retrospective Studies | 2012 |
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Female; Genotype; Humans; Male; MicroRNAs; Middle Aged; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis; Pyrimidines; Recurrence; Treatment Outcome | 2012 |
Image analysis for quantitation of solid tumor drug sensitivity.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Osmolar Concentration; Pyrimidines; Rats; Single-Blind Method | 1999 |
The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
Topics: Adenocarcinoma; Colonic Neoplasms; Combined Modality Therapy; Dipyridamole; DNA Repair; DNA, Neoplasm; Drug Synergism; Humans; Leucovorin; Pyrimidines; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1991 |
Biochemical modulation of 5-fluoropyrimidine toxicity by dehydroepiandrosterone in human colonic adenocarcinoma cells.
Topics: Adenocarcinoma; Carbon Radioisotopes; Colonic Neoplasms; Dehydroepiandrosterone; Fluorouracil; Humans; Interphase; Pyrimidines; Thymidine; Thymidine Monophosphate; Tumor Cells, Cultured; Uracil | 1990 |
Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma.
Topics: Adenocarcinoma; Aphidicolin; Cell Line; Cell Survival; Colonic Neoplasms; Diterpenes; DNA; DNA Damage; Drug Synergism; Floxuridine; Fluorouracil; Humans; Leucovorin; Pyrimidines; Thymidine | 1988 |
Incorporation of pyrimidines and 5-fluoropyrimidines into normal tissues and an adenocarcinoma transplanted into the liver in rat.
Topics: Adenocarcinoma; Animals; Female; Liver Neoplasms; Neoplasm Transplantation; Pyrimidines; Rats; Rats, Inbred WF | 1985 |